Favorable Outcomes Combining Vedolizumab with Other Biologics or Tofacitinib for Treatment of Inflammatory Bowel Disease

Ernesto M. Llano, Shreeju Shrestha, Ezra Burstein, Moheb Boktor, David I. Fudman

Research output: Contribution to journalArticlepeer-review

3 Scopus citations

Fingerprint

Dive into the research topics of 'Favorable Outcomes Combining Vedolizumab with Other Biologics or Tofacitinib for Treatment of Inflammatory Bowel Disease'. Together they form a unique fingerprint.

Medicine & Life Sciences